Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis

Leukemia - United Kingdom
doi 10.1038/leu.2012.274
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Stem Cell Transplantation Compared With Melphalan Plus Dexamethasone in the Treatment of Immunoglobulin Light-Chain Amyloidosis

Cancer
Cancer ResearchOncology
2016English

Combination of Bortezomib in the Induction, Conditioning and Consolidation With Autologous Hematopoietic Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis

American Journal of Hematology
Hematology
2019English

Timing of Stem Cell Transplantation and Outcomes in Light Chain Amyloidosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients With Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Impact of Prior Melphalan Exposure on Stem Cell Collection in Light Chain Amyloidosis

Bone Marrow Transplantation
TransplantationHematology
2017English

Outcomes of 44 Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion 17p

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Rates of Engraftment Syndrome After Autologous Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy